Physician profile
Monique Chang
NPI 1255381653
$16,574.52
in general payments reported to CMS, 2019-2025
74 companies · $4,753 in 2025
The $4,753 reported for 2025 was more than what 81% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,170 · 2020: $853 · 2021: $2,068 · 2022: $1,517 · 2023: $2,229 · 2024: $3,985 · 2025: $4,753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,414.18 |
| Education | $552.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,478.90 | 2019-2025 | Enhertu, Lynparza, Imfinzi |
| Janssen Biotech, INC. | $1,230.91 | 2019-2025 | Darzalex, Tecvayli, Talvey |
| Novartis Pharmaceuticals Corporation | $1,159.89 | 2019-2025 | |
| Pfizer INC. | $924.30 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $876.33 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Daiichi Sankyo INC. | $875.97 | 2019-2025 | Enhertu, Vanflyta, Injectafer |
| Astellas Pharma US INC | $550.17 | 2019-2025 | Padcev, Xospata, Vyloy |
| E.R. Squibb & Sons, L.L.C. | $536.54 | 2019-2025 | Opdivo |
| Gilead Sciences, INC. | $463.78 | 2019-2025 | Trodelvy |
| Abbvie INC. | $438.96 | 2020-2025 | |
| Genzyme Corporation | $426.91 | 2019-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $399.41 | 2019-2023 | Imbruvica |
| Amgen INC. | $376.68 | 2019-2023 | Lumakras, Xgeva, Vectibix |
| Takeda Pharmaceuticals U.S.A., INC. | $327.63 | 2021-2025 | Fruzaqla, Iclusig, Alunbrig |
| Celgene Corporation | $314.09 | 2021-2025 | Reblozyl, Pomalyst |
Show all 74 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $313.31 | 2019-2025 | Polivy, Gavreto, Alecensa |
| Glaxosmithkline, LLC. | $310.79 | 2020-2025 | Ojjaara, Jemperli, Zejula |
| Incyte Corporation | $286.64 | 2019-2025 | Monjuvi, Jakafi, Pemazyre |
| Rigel Pharmaceuticals, INC. | $281.70 | 2020-2024 | Tavalisse, Rezlidhia |
| Seagen INC. | $276.44 | 2019-2023 | Tukysa, Adcetris, Padcev |
| Eisai INC. | $275.46 | 2019-2025 | |
| Pharmacosmos Therapeutics INC. | $246.06 | 2023-2025 | Monoferric |
| Blueprint Medicines Corporation | $246.03 | 2020-2025 | Ayvakit |
| Regeneron Healthcare Solutions, INC. | $239.41 | 2021-2025 | Libtayo |
| Tersera Therapeutics LLC | $226.04 | 2023-2025 | Zoladex |
| Bayer Healthcare Pharmaceuticals INC. | $215.35 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $198.41 | 2023-2025 | Ultomiris |
| Aveo Pharmaceuticals, INC. | $197.06 | 2022-2025 | Fotivda |
| Endomagnetics LTD | $195.75 | 2023 | Magseed, Magtrace |
| Stemline Therapeutics INC. | $185.66 | 2024-2025 | Orserdu |
| Array Biopharma INC | $163.96 | 2021-2025 | Braftovi, Mektovi, Tukysa |
| Puma Biotechnology, INC. | $159.00 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.61 | 2019-2025 | |
| Beone Medicines USA, INC. | $132.91 | 2025 | Brukinsa, Tevimbra |
| Tempus Ai, INC | $132.59 | 2024-2025 | Xt Cdx |
| Genmab U.S., INC. | $112.39 | 2024 | Tivdak, Epkinly |
| Ipsen Biopharmaceuticals, INC | $104.99 | 2020-2025 | Onivyde |
| Emd Serono, INC. | $102.12 | 2019-2025 | Bavencio |
| Jazz Pharmaceuticals INC. | $95.50 | 2020-2025 | |
| Sobi, INC | $95.32 | 2022-2025 | |
| Kite Pharma, INC. | $90.79 | 2020-2023 | |
| Sun Pharmaceutical Industries INC. | $83.77 | 2023-2025 | Odomzo, Yonsa |
| Karyopharm Therapeutics INC. | $68.36 | 2020-2025 | Xpovio |
| Lilly USA, LLC | $65.44 | 2019-2025 | Jaypirca, Verzenio |
| Springworks Therapeutics, INC. | $64.71 | 2024-2025 | Ogsiveo |
| Deciphera Pharmaceuticals INC. | $64.65 | 2025 | Qinlock, Romvimza |
| Coherus Oncology, INC. | $61.11 | 2025 | Loqtorzi |
| Pharmaessentia USA Corporation | $57.50 | 2025 | Besremi |
| Sumitomo Pharma America, INC. | $56.06 | 2024 | Orgovyx |
| Beigene USA, INC. | $54.38 | 2024-2025 | Brukinsa, Tevimbra |
| Mirati Therapeutics, INC. | $51.13 | 2023 | Krazati |
| Myovant Sciences INC. | $41.06 | 2022 | |
| Adc Therapeutics America, INC. | $38.55 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $38.19 | 2019-2024 | Xarelto |
| Tg Therapeutics, INC. | $34.65 | 2021 | |
| Syndax Pharmaceuticals, INC. | $31.55 | 2025 | |
| G1 Therapeutics, INC. | $30.17 | 2022-2023 | Cosela |
| Geron Corporation | $29.85 | 2025 | Rytelo |
| Foundation Medicine, INC. | $24.61 | 2021 | |
| Iovance Biotherapeutics, INC. | $23.23 | 2025 | Amtagvi |
| Exelixis INC. | $22.48 | 2025 | Cabometyx |
| Servier Pharmaceuticals LLC | $22.27 | 2025 | |
| Epizyme, INC. | $21.97 | 2020 | |
| Amneal Pharmaceuticals LLC | $21.77 | 2025 | Alymsys |
| Fennec Pharmaceuticals, INC. | $20.21 | 2025 | Fyarro |
| Legend Biotech USA INC. | $19.85 | 2025 | Carvykti |
| Clovis Oncology, INC. | $18.76 | 2021 | |
| Acrotech Biopharma INC. | $18.44 | 2025 | Beleodaq |
| Myriad Genetic Laboratories, INC. | $15.31 | 2025 | Precisetumor |
| Agios Pharmaceuticals, INC. | $15.26 | 2025 | Pyrukynd |
| Mylan Institutional INC. | $14.76 | 2019 | |
| Caris Mpi, INC. | $13.89 | 2025 | Mi Cancer Seek |
| Catalyst Pharmaceuticals, INC. | $13.49 | 2023 | Firdapse |
| Pharmaand Gmbh | $13.33 | 2025 | Rubraca |
Drugs and devices associated with these payments
Enhertu $847Keytruda $664Tukysa $482Lynparza $473Darzalex $430Imbruvica $392Tecvayli $356Kisqali $330Talvey $264Monoferric $246Zoladex $226Epkinly $217Ibrance $216Ultomiris $198Magseed $196Magtrace $196Imfinzi $189Reblozyl $188Ayvakit $186Orserdu $186Fotivda $178Libtayo $174Lenvima $166Braftovi $138Mektovi $138Brukinsa $132Tavalisse $130Rezlidhia $130Lutathera $128Orgovyx $127Xtandi $125Welireg $120Xt Cdx $115Erleada $111Opdivo $105Adcetris $98.76Stivarga $95.61Vitrakvi $95.61Scemblix $95.60Padcev $95.10Elrexfio $93.54Ojjaara $92.57Trodelvy $91.91Fabhalta $89.73Fruzaqla $88.45Pluvicto $88.25Jemperli $84.51Talzenna $84.19Odomzo $83.77Yonsa $83.77Polivy $83.62Vanflyta $80.92Iclusig $78.92Balversa $73.89Rybrevant $73.36Sarclisa $70.12Akeega $66.69Ogsiveo $64.71Qinlock $64.65Carvykti $62.01Loqtorzi $61.11Onivyde $60.52Bosulif $60.16Zejula $59.08Gavreto $58.50Alecensa $58.50Alunbrig $58.09Besremi $57.50Injectafer $56.86Tivdak $56.79Tevimbra $55.78Monjuvi $53.78Zepzelca $52.83Vonjo $52.06Xospata $51.77Krazati $51.13Keytruda Qlex $50.76Venclexta $49.35Ninlaro $43.96Wayrilz $41.60Lorbrena $41.36Bavencio $40.47Columvi $40.06Lunsumio $40.06Jakafi $39.16Rozlytrek $35.28Tecentriq $35.28Nerlynx $34.73Comirnaty $34.69Cablivi $34.43Enjaymo $34.43Tasigna $33.62Promacta $33.60Jaypirca $31.40Verzenio $31.40Romvimza $31.11Vyloy $29.87Rytelo $29.85Cresemba $28.16Pemazyre $28.16
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monique Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.